---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-005075"
form_type: "8-K"
ticker: "EWTX"
cik: "0001710072"
company_name: "Edgewise Therapeutics, Inc."
filed_at: "2025-01-22T23:59:59+00:00"
generated_at: "2026-05-27T19:55:43.975701+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Edgewise Therapeutics promotes Behrad Derakhshan to COO

## Summary
- Behrad Derakhshan, Ph.D., appointed Chief Operating Officer effective January 8, 2025.
- Previously served as Chief Business Officer since September 2020.
- Annual base salary increased from $478,400 to $520,000; target bonus raised to 45%.
- No family relationships with any director or executive officer of the company.

## SEC filing metadata
- accession: 0001104659-25-005075
- form_type: 8-K
- ticker: EWTX
- cik: 0001710072
- company_name: Edgewise Therapeutics, Inc.
- filed_at: 2025-01-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1710072/000110465925005075/0001104659-25-005075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1710072/000110465925005075/tm253635d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-005075
- JSON: https://secwatch.observer/filing/0001104659-25-005075.json
- Plain text: https://secwatch.observer/filing/0001104659-25-005075.txt

## Key facts
- Executive change
  Behrad Derakhshan changed role as Chief Operating Officer at Edgewise Therapeutics, Inc..
  - Action: promoted
  - Role: Chief Operating Officer
  source text: On January 8, 2025, the Board of Directors (the “ Board ”) of Edgewise Therapeutics, Inc. (the “ Company ”) promoted Behrad Derakhshan, Ph.D. to the role of Chief Operating Officer of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1710072/000110465925005075/0001104659-25-005075-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.